Nephros, Inc. (NEPH)

Market Cap	41.34M
Revenue (ttm)	16.68M
Net Income (ttm)	1.33M
Shares Out	10.60M
EPS (ttm)	0.12
PE Ratio	32.72
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151,165
Open	3.400
Previous Close	2.890
Day's Range	3.211 - 4.070
52-Week Range	1.364 - 5.000
Beta	1.11
Analysts	Strong Buy
Price Target	5.50 (+41.03%)
Earnings Date	Aug 7, 2025

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters th...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Analyst Summary

According to 2 analysts, the average rating for NEPH stock is "Strong Buy." The 12-month stock price target is $5.5, which is an increase of 41.03% from the latest price.

Price Target

$5.5

(41.03% upside)

Analyst Consensus: Strong Buy